Variant report
Variant | esv3509342 |
---|---|
Chromosome Location | chr16:80196706-80197192 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:80192745..80194874-chr16:80195006..80196730,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs8044077 | chr16:80196714-80196715 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs542834135 | chr16:80196758-80196759 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs146819065 | chr16:80196759-80196760 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs576100886 | chr16:80196781-80196782 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs543008297 | chr16:80196817-80196818 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs564959661 | chr16:80196847-80196848 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs535205266 | chr16:80196891-80196892 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs191495567 | chr16:80196895-80196896 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs532025274 | chr16:80196897-80196898 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs74964959 | chr16:80196900-80196901 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs374130446 | chr16:80196903-80196904 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs200094516 | chr16:80196904-80196905 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs201274980 | chr16:80196905-80196906 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs541315153 | chr16:80196907-80196908 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs183356946 | chr16:80196924-80196925 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187851845 | chr16:80196936-80196937 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs369338233 | chr16:80197010-80197011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs202092434 | chr16:80197047-80197048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs140565377 | chr16:80197063-80197064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531043966 | chr16:80197066-80197067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552561154 | chr16:80197078-80197079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570858916 | chr16:80197083-80197084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs535061876 | chr16:80197092-80197093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs571804391 | chr16:80197099-80197100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs373615068 | chr16:80197106-80197107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs143156142 | chr16:80197108-80197109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs565984806 | chr16:80197133-80197134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs536024116 | chr16:80197134-80197135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs554755015 | chr16:80197146-80197147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs576007334 | chr16:80197151-80197152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs4889115 | chr16:80197159-80197160 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs151192428 | chr16:80197175-80197176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs576412726 | chr16:80197183-80197184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192736686 | chr16:80197185-80197186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Autism | 21865298 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:80186600-80197600 | Weak transcription | HSMMtube | muscle |
2 | chr16:80192800-80197600 | Weak transcription | Pancreas | Pancrea |
3 | chr16:80193200-80199600 | Weak transcription | A549 | lung |
4 | chr16:80193400-80197600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr16:80193400-80197800 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
6 | chr16:80193400-80197800 | Weak transcription | Osteobl | bone |
7 | chr16:80193400-80199200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr16:80193600-80197400 | Weak transcription | HSMM | muscle |
9 | chr16:80193600-80197600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr16:80193600-80197600 | Weak transcription | NH-A | brain |
11 | chr16:80193600-80197800 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
12 | chr16:80193600-80201400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
13 | chr16:80193600-80207600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
14 | chr16:80193800-80201400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
15 | chr16:80196200-80197000 | Enhancers | Fetal Kidney | kidney |
16 | chr16:80197000-80200800 | Weak transcription | Fetal Kidney | kidney |